Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
作者信息
Harvey R J, Sciulli C G, Mason R M, Whitehouse P J
机构信息
Dementia Research Group, National Hospital for Neurology and Neurosurgery, London, U.K.
出版信息
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:29-32.
PMID:9305512
Abstract
摘要
相似文献
1
Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:29-32.
2
Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:6-7.
3
Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.痴呆症药物临床试验中的翻译问题。痴呆症药物指南协调国际工作组的立场文件。
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:61-4.
4
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.临床试验中痴呆症的诊断标准。痴呆症药物指南协调国际工作组的立场文件。
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:22-5.
5
6
Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:54-5.
7
Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:26-8.
8
Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:56-60.
9
Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:19-21.
10
Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.痴呆症治疗的经济评估问题。痴呆症药物指南协调国际工作组的立场文件。
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:39-45.
Zotero 插件